Average daily dose, medication adherence, and healthcare costs among commercially-insured patients with fibromyalgia treated with duloxetine

By Wu N   Chen S   Boulanger L   Rao P   Zhao Y  

Current Medical Research and Opinion, Vol. 27, Iss. 6, 2011-06 ,pp. : 1131-1139

Informa Healthcare

Access to resources Recommend Favorite

Ways of coping with cystic fibrosis: implications for treatment adherence

By Abbott Janice   Dodd Mary   Gee Louise   Webb Kevin  

Disability and Rehabilitation, Vol. 23, Iss. 8, 2001-05 ,pp. : 315-324

Informa Healthcare

Access to resources Recommend Favorite

Impact of co‐morbidities on resource use and adherence to guidelines among commercially insured adults with new visits for back pain

By  

JOURNAL OF EVALUATION IN CLINICAL PRACTICE (ELECTRONIC), Vol. 23, Iss. 6, 2017-12 ,pp. : 1218-1226

John Wiley & Sons Inc

Access to resources Recommend Favorite

Rates and predictors of antipsychotic non-adherence and hospitalization in Medicaid and commercially-insured patients with schizophrenia

By Lang Kathleen  

Journal of Medical Economics, Vol. 16, Iss. 8, 2013-08 ,pp. : 997-1006

Informa Healthcare

Access to resources Recommend Favorite

Prevalence of Pre-Existing Risk Factors for Adverse Events Associated with Atypical Antipsychotics Among Commercially Insured and Medicaid Insured Patients Newly Initiating Atypical Antipsychotics

By  

Current Drug Safety, Vol. 9, Iss. 3, 2014-11 ,pp. : 227-235

Bentham Science Publishers

Access to resources Recommend Favorite